Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer

Oral Diseases

Volumn 18, Issue 8, 2012, Pages 734-740

  Lin, C W ^a,b   Tseng, S W ^a,b   Yang, S F ^a,b   Ko, C P ^a,c   Lin, C H ^d   Wei, L H ^e   Chien, M H ^d,f   Hsieh, Y S ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Lipocalin 2; Matrix metalloproteinase 9; Oral squamous cell carcinoma

Indexed keywords

GELATINASE B; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME;

ACUTE-PHASE PROTEINS; ARECA; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; HUMANS; LIPOCALINS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 84866871900     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2012.01938.x     Document Type: Article

References (35)

1. Alcalde RE, Shintani S, Yoshihama Y, Matsumura T (1995). Cell proliferation and tumor angiogenesis in oral squamous cell carcinoma. Anticancer Res15: 1417-1422.
2. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A (2008). Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat108: 389-397.
3. Bratt T (2000). Lipocalins and cancer. Biochim Biophys Acta1482: 318-326.
4. Choi S, Myers JN (2008). Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res87: 14-32.
5. Cowland JB, Borregaard N (1997). Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics45: 17-23.
6. Devireddy LR, Gazin C, Zhu X, Green MR (2005). A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell123: 1293-1305.
7. Fernandez CA, Yan L, Louis G, Yang J, Kutok JL, Moses MA (2005). The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res11: 5390-5395.
8. Friedl A, Stoesz SP, Buckley P, Gould MN (1999). Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J31: 433-441.
9. Furutani M, Arii S, Mizumoto M, Kato M, Imamura M (1998). Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett122: 209-214.
10. Goetz DH, Willie ST, Armen RS, Bratt T, Borregaard N, Strong RK (2000). Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry39: 1935-1941.
11. Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, Cantley LG (2005). Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem280: 7875-7882.
12. Haase-Fielitz A, Bellomo R, Devarajan P et al (2009). The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant24: 3349-3354.
13. Hiromoto T, Noguchi K, Yamamura M et al (2011). Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: relation to cell differentiation. Oncol Rep26: 1415-1421.
14. Hu L, Hittelman W, Lu T et al (2009). NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest89: 531-548.
15. Kubben FJ, Sier CF, Hawinkels LJ et al (2007). Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer43: 1869-1876.
16. Laurell H, Bouisson M, Berthelemy P et al (2006). Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol12: 3344-3351.
17. Lim R, Ahmed N, Borregaard N et al (2007). Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer120: 2426-2434.
18. Macluskey M, Chandrachud LM, Pazouki S et al (2000). Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression. J Pathol191: 368-375.
19. Mira E, Lacalle RA, Buesa JM et al (2004). Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci117: 1847-1857.
20. Mori K, Yang J, Barasch J (2003). Ureteric bud controls multiple steps in the conversion of mesenchyme to epithelia. Semin Cell Dev Biol14: 209-216.
21. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L (1996). Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut38: 414-420.
22. Nuntagowat C, Leelawat K, Tohtong R (2010). NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation. Clin Exp Metastasis27: 295-305.
23. Okada Y, Ueno H, Katagiri M et al (2010). Experimental study of antiangiogenic gene therapy targeting VEGF in oral cancer. Odontology98: 52-59.
24. Provatopoulou X, Gounaris A, Kalogera E et al (2009). Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer9: 390.
25. Saiga H, Nishimura J, Kuwata H et al (2008). Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol181: 8521-8527.
26. Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K, Hamakawa H (2004). Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol40: 13-20.
27. Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA (2008). Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res14: 2378-2386.
28. Somiari SB, Shriver CD, Heckman C et al (2006). Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett233: 98-107.
29. Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, Gould MN (1998). Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer79: 565-572.
30. Tong Z, Kunnumakkara AB, Wang H et al (2008). Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res68: 6100-6108.
31. Tsai HT, Su PH, Lee TH et al (2011). Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease. Clin Chim Acta412: 1252-1256.
32. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ (1994). Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg168: 373-380.
33. Yan L, Borregaard N, Kjeldsen L, Moses MA (2001). The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem276: 37258-37265.
34. Yang J, Goetz D, Li JY et al (2002). An iron delivery pathway mediated by a lipocalin. Mol Cell10: 1045-1056.
35. Zhang H, Xu L, Xiao D et al (2007). Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol60: 555-561.